235 related articles for article (PubMed ID: 17334356)
1. Autocatalytic cleavage of Clostridium difficile toxin B.
Reineke J; Tenzer S; Rupnik M; Koschinski A; Hasselmayer O; Schrattenholz A; Schild H; von Eichel-Streiber C
Nature; 2007 Mar; 446(7134):415-9. PubMed ID: 17334356
[TBL] [Abstract][Full Text] [Related]
2. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
Jank T; Aktories K
Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
[TBL] [Abstract][Full Text] [Related]
3. Self-cutting to kill: new insights into the processing of Clostridium difficile toxins.
Aktories K
ACS Chem Biol; 2007 Apr; 2(4):228-30. PubMed ID: 17455899
[TBL] [Abstract][Full Text] [Related]
4. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.
Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S
J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255
[TBL] [Abstract][Full Text] [Related]
5. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
Egerer M; Giesemann T; Herrmann C; Aktories K
J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
[TBL] [Abstract][Full Text] [Related]
6. The role of toxin A and toxin B in the virulence of Clostridium difficile.
Carter GP; Rood JI; Lyras D
Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.
Genisyuerek S; Papatheodorou P; Guttenberg G; Schubert R; Benz R; Aktories K
Mol Microbiol; 2011 Mar; 79(6):1643-54. PubMed ID: 21231971
[TBL] [Abstract][Full Text] [Related]
8. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
Jank T; Giesemann T; Aktories K
Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
[TBL] [Abstract][Full Text] [Related]
9. Glucosylation of Rho proteins by Clostridium difficile toxin B.
Just I; Selzer J; Wilm M; von Eichel-Streiber C; Mann M; Aktories K
Nature; 1995 Jun; 375(6531):500-3. PubMed ID: 7777059
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
[TBL] [Abstract][Full Text] [Related]
11. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
Faust C; Ye B; Song KP
Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
[TBL] [Abstract][Full Text] [Related]
12. Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro.
Trejo FM; Pérez PF; De Antoni GL
Antonie Van Leeuwenhoek; 2010 Jun; 98(1):19-29. PubMed ID: 20232250
[TBL] [Abstract][Full Text] [Related]
13. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.
Duncan PI; Fotopoulos G; Pasche E; Porta N; Masserey Elmelegy I; Sanchez-Garcia JL; Bergonzelli GE; Corthésy-Theulaz I
FEMS Microbiol Lett; 2009 Jun; 295(2):218-25. PubMed ID: 19416358
[TBL] [Abstract][Full Text] [Related]
14. EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.
Majumder S; Schmidt G; Lohia A; Aktories K
Appl Environ Microbiol; 2006 Dec; 72(12):7842-8. PubMed ID: 17056697
[TBL] [Abstract][Full Text] [Related]
15. Large clostridial cytotoxins.
Just I; Gerhard R
Rev Physiol Biochem Pharmacol; 2004; 152():23-47. PubMed ID: 15449191
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
17. Microfilament-disrupting Clostridium difficile toxin B causes multinucleation of transformed cells but does not block capping of membrane Ig.
Shoshan MC; Aman P; Skog S; Florin I; Thelestam M
Eur J Cell Biol; 1990 Dec; 53(2):357-63. PubMed ID: 2081549
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the function of Clostridium difficile toxin B.
Reinert DJ; Jank T; Aktories K; Schulz GE
J Mol Biol; 2005 Sep; 351(5):973-81. PubMed ID: 16054646
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.
Rupnik M
FEMS Microbiol Rev; 2008 May; 32(3):541-55. PubMed ID: 18397287
[TBL] [Abstract][Full Text] [Related]
20. Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion.
Spyres LM; Qa'Dan M; Meader A; Tomasek JJ; Howard EW; Ballard JD
Infect Immun; 2001 Jan; 69(1):599-601. PubMed ID: 11119561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]